SCHEMBL4484480

SCHEMBL4484480

COc1ccc(C2(N3C[C@H](F)C[C@H]3C(=O)N(C)C)C(=O)Nc3cc(OC)c(OC)cc32)c(OC)c1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AVPR1B P47901 10/20 0.43
AVPR1A P37288 9/20 0.43
OXTR P30559 9/20 0.43
AVPR2 P30518 3/20 0.43
GPR65 Q8IYL9 1/20 0.43
NQO2 P16083 1/20 0.34
GAA P10253 1/20 0.33
KMT2A Q03164 2/20 0.33
LMNA P02545 2/20 0.33
MDM2 Q00987 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PDE4B Q07343 1/20 0.32
MEN1 O00255 1/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
ACHE P22303 2/20 0.32
DDB1 Q16531 1/20 0.32
CRBN Q96SW2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2497563 0.81 AVPR1A (0.43) AVPR1BAVPR1AOXTRAVPR2GPR65
SCHEMBL2495296 0.80 AVPR1B (0.60) AVPR1BAVPR1AOXTRAVPR2GPR65
SCHEMBL2495745 0.80 AVPR1A (0.42) AVPR1BAVPR1AOXTRAVPR2GPR65
SCHEMBL4484568 0.80 AVPR1B (0.63) AVPR1BAVPR1AOXTRAVPR2GPR65
SCHEMBL2499389 0.79 AVPR1A (0.52) AVPR1BAVPR1AOXTRAVPR2GPR65
SCHEMBL4479387 0.79 AVPR1A (0.52) AVPR1BAVPR1AOXTRAVPR2GPR65
SCHEMBL2499338 0.79 AVPR1A (0.52) AVPR1BAVPR1AOXTRAVPR2GPR65
SCHEMBL2500497 0.79 AVPR1A (0.52) AVPR1BAVPR1AOXTRAVPR2GPR65
SCHEMBL2495932 0.76 AVPR1B (0.57) AVPR1BAVPR1AOXTRAVPR2GPR65
SCHEMBL2499794 0.75 AVPR1B (0.58) AVPR1BAVPR1AOXTRAVPR2GPR65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7528124-B2 1,3-dihydro-2H-indol-2-one derivative TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-05-05 US disclosed
US-20060276449-A1 1,3-Dihydro-2h-indol-2-one derivative TAISHO PHARMACEUTICAL CO., LTD. (JP) 2006-12-07 US disclosed
EP-1659121-A1 1,3-DIHYDRO-2H-INDOL-2-ONE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2006-05-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276449-A1 1,3-Dihydro-2h-indol-2-one derivative AVPR1B, AVPR2, AVPR1A AVPR1B 1/4885AVPR1A 3/4885OXTR 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.